HUMANISIERTE ODER CHIMÄRE CD3-ANTIKÖRPER
European patent · EP4249515 · In force
Register entry
- Publication number
- EP4249515
- Application number
- EP23174159
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 8, 2015
- Published
- Sep 27, 2023
- Granted
- Jun 18, 2025
- Protection ends at the latest
- Jan 7, 2035
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 39/00 (2006.01)A61P 35/00 (2006.01)A61P 37/06 (2006.01)C07K 16/10 (2006.01)C07K 16/28 (2006.01)C07K 16/32 (2006.01)
- Priority
- DK PA201400009 09.01.2014WO PCT/EP2014/050340 09.01.2014WO PCT/EP2014/064326 04.07.2014
- Divided from
- EP15700081
- Filing language
- English
- Source
- Swissreg
Supplementary protection certificates
A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 30, 2026
Change
Published in Swissreg on 30.04.2026
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Aug 21, 2025
Agent entered
- Representative
- E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 21.08.2025
- Jun 18, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.06.2025
Parties
Inventor
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
NL-3584 Utrecht, NL
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.